Abiopharma

Director Custin Ann 🟢 acquired 363 shares of ESTABLISHMENT LABS HOLDINGS INC. (ESTA) at $56.78 Transaction Date: Mar 31, 2026 | Filing ID: 000002

Durso Jerome Benedict 🟢 acquired 15.0K shares of Altimmune, Inc. (ALT) at $3.14 Transaction Date: Apr 01, 2026 | Filing ID: 000005

Jin David 🟢 acquired 3.0K shares of Fortress Biotech, Inc. (FBIO) at $2.18 Transaction Date: Apr 01, 2026 | Filing ID: 000002

Director Brady Brian W 🟢 acquired 4.3K shares of IZEA Worldwide, Inc. (IZEA) Transaction Date: Mar 31, 2026 | Filing ID: 000004

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

Nasdaq to Hold First Quarter 2026 Investor Conference Call

Parsons to Announce First Quarter 2026 Financial Results on April 29, 2026

TransUnion Completes Acquisition of the Mobile Division of RealNetworks

Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors

Robinhood Markets, Inc. to Announce First Quarter 2026 Results on April 28, 2026

QCR Holdings, Inc. to Report First Quarter 2026 Financial Results

ADC Therapeutics Announces New Employee Inducement Grant

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Horizon Bancorp, Inc. Announces Conference Call to Review First Quarter Results on April 23

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026